Harbour Investment Management LLC Novo Nordisk A S Transaction History

Harbour Investment Management LLC

$224 Million
Q3 2024

A detailed history of Harbour Investment Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Harbour Investment Management LLC holds 84,551 shares of NVO stock, worth $8.96 Million. This represents 4.5% of its overall portfolio holdings.

Number of Shares

84,551

Previous 88,766 4.75%

Holding current value

$8.96 Million

Previous $12.7 Million 20.54%

% of portfolio

4.5%

Previous 5.9%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$119.07 - $145.42 $501,880 - $612,945	-4,215 Reduced 4.75%	84,551 $10.1 Million
Q2 2024 Jul 22, 2024	SELL	$122.71 - $146.91 $469,243 - $561,783	-3,824 Reduced 4.13%	88,766 $12.7 Million
Q1 2024 May 08, 2024	SELL	$102.11 - $135.92 $122,532 - $163,103	-1,200 Reduced 1.28%	92,590 $11.9 Million
Q4 2023 Feb 09, 2024	SELL	$87.78 - $105.45 $212,427 - $255,189	-2,420 Reduced 2.52%	93,790 $9.7 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $4.25 Million - $9.33 Million	46,760 Added 94.56%	96,210 $8.75 Million
Q2 2023 Aug 11, 2023	SELL	$155.98 - $172.65 $155,356 - $171,959	-996 Reduced 1.97%	49,450 $8 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $14,557 - $17,505	-110 Reduced 0.22%	50,446 $8.03 Million
Q4 2022 Feb 10, 2023	SELL	$102.55 - $135.33 $87,167 - $115,030	-850 Reduced 1.65%	50,556 $6.84 Million
Q3 2022 Nov 15, 2022	SELL	$95.28 - $116.93 $21,914 - $26,893	-230 Reduced 0.45%	51,406 $5.12 Million
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $126,985 - $149,826	-1,230 Reduced 2.33%	51,636 $5.75 Million
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $93,658 - $113,215	-1,006 Reduced 1.87%	52,866 $5.87 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $9,588 - $11,708	-100 Reduced 0.19%	53,872 $6.03 Million
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $35,456 - $44,780	-420 Reduced 0.77%	53,972 $5.18 Million
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $60,758 - $76,114	898 Added 1.68%	54,392 $4.56 Million
Q1 2021 May 17, 2021	SELL	$67.06 - $75.82 $44,930 - $50,799	-670 Reduced 1.24%	53,494 $3.61 Million
Q3 2020 Oct 22, 2020	BUY	$63.69 - $70.22 $100,439 - $110,736	1,577 Added 3.0%	54,164 $3.76 Million
Q2 2020 Jul 31, 2020	SELL	$58.54 - $67.94 $87,810 - $101,910	-1,500 Reduced 2.77%	52,587 $3.44 Million
Q1 2020 Apr 17, 2020	SELL	$49.46 - $64.78 $8,408 - $11,012	-170 Reduced 0.31%	54,087 $3.26 Million
Q4 2019 Feb 04, 2020	SELL	$49.86 - $58.26 $4,138 - $4,835	-83 Reduced 0.15%	54,257 $3.14 Million
Q3 2019 Nov 08, 2019	SELL	$47.54 - $53.43 $26,147 - $29,386	-550 Reduced 1.0%	54,340 $2.81 Million
Q2 2019 Jul 26, 2019	SELL	$46.79 - $52.47 $14,972 - $16,790	-320 Reduced 0.58%	54,890 $2.8 Million
Q1 2019 May 03, 2019	SELL	$46.36 - $52.63 $56,791 - $64,471	-1,225 Reduced 2.17%	55,210 $2.89 Million
Q4 2018 Feb 08, 2019	SELL	$41.54 - $47.25 $34,270 - $38,981	-825 Reduced 1.44%	56,435 $2.6 Million
Q3 2018 Nov 05, 2018	SELL	$46.76 - $51.24 $14,028 - $15,372	-300 Reduced 0.52%	57,260 $2.7 Million
Q2 2018 Jul 31, 2018	SELL	$44.29 - $50.42 $54,698 - $62,268	-1,235 Reduced 2.1%	57,560 $2.66 Million
Q1 2018 Apr 30, 2018	SELL	$48.49 - $58.14 $61,339 - $73,547	-1,265 Reduced 2.11%	58,795 $2.9 Million
Q4 2017 Feb 02, 2018	SELL	$47.53 - $53.73 $390,696 - $441,660	-8,220 Reduced 12.04%	60,060 $3.22 Million
Q3 2017 Nov 07, 2017	BUY	$41.15 - $49.22 $2.81 Million - $3.36 Million	68,280	68,280 $3.29 Million

Others Institutions Holding NVO

# of Institutions

1,956

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $239B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investment Management LLC with notifications on news.

Account

Harbour Investment Management LLC Novo Nordisk A S Transaction History